Loading [Contrib]/a11y/accessibility-menu.js

Metrics
Cost-effectiveness Analysis of Lorlatinib in Patients Previously Treated with Anaplastic Lymphoma Kinase Inhibitors for Non-small Cell Lung Cancer in Greece

George Gourzoulidis, Oresteia Zisimopoulou, Nadia Boubouchairopoulou, Christina Michailidi, Chrissy Lowry, Charalampos Tzanetakos, Georgia Kourlaba,
• https://doi.org/10.36469/jheor.2022.32983
Top Countries
IN19
US16
GR8
SG8
CN4
GB4
BR3
CA2
ES2
MX2